Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 10, 2005, Pages 4335-4338

  Johnson, Christine M ^a   Pandey, Rajesh ^b   Sharma, Sadhna ^b   Khuller, G K ^b   Basaraba, Randall J ^a   Orme, Ian M ^a   Lenaerts, Anne J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; NANOPARTICLE; POLYGLACTIN; PYRAZINAMIDE; RIFAMPICIN; SUCROSE; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; FEMALE; GUINEA PIG; HISTOPATHOLOGY; LUNG TUBERCULOSIS; MICROENCAPSULATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANIMALS; ANTITUBERCULAR AGENTS; CAPSULES; DRUG CARRIERS; FEMALE; GUINEA PIGS; LUNG; MYCOBACTERIUM TUBERCULOSIS; NANOSTRUCTURES; TUBERCULOSIS;

EID: 25844444106     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.10.4335-4338.2005     Document Type: Article

References (11)

1. Blumberg, H. M., W. J. Burman, R. E. Chaisson, C. L. Daley, S. C. Etkind, L. N. Friedman, P. Fujiwara, M. Grzemska, P. C. Hopewell, M. D. Iseman, R. M. Jasmer, V. Koppaka, R. I. Menzies, R. J. O'Brien, R. R. Reves, L. B. Reichman, P. M. Simone, J. R. Starke, A. A. Vernon, et al. 2003. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 167:603-662.
2. Brandt, L., Y. A. Skeiky, M. R. Alderson, Y. Lobet, W. Dalemans, O. C. Turner, R. J. Basaraba, A. A. Izzo, T. M. Lasco, P. L. Chapman, S. G. Reed, and I. M. Orme. 2004. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infect. Immun. 72:6622-6632.
3. Kraft, S. L., D. Dailey, M. Kovach, K. L. Stasiak, J. Bennett, C. T. McFarland, D. N. McMurray, A. A. Izzo, I. M. Orme, and R. J. Basaraba. 2004. Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect. Immun. 72:5963-5971.
4. Lasco, T. M., O. C. Turner, L. Cassone, I. Sugawara, H. Yamada, D. N. McMurray, and I. M. Orme. 2004. Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect. Immun. 72:1147-1149.
5. McMurray, D. N., F. M. Collins, A. M. Dannenberg, Jr., and D. W. Smith. 1996. Pathogenesis of experimental tuberculosis in animal models. Curr. Top. Microbiol. Immunol. 215:157-179.
6. Pandey, R., A. Sharma, A. Zahoor, S. Sharma, G. K. Khuller, and B. Prasad. 2003. Poly (dL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J. Antimicrob. Chemother. 52:981-986.
7. Pandey, R., A. Zahoor, S. Sharma, and G. K. Khuller. 2003. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis (Edinburgh) 83:373-378.
8. Sharma, A., R. Pandey, S. Sharma, and G. K. Khuller. 2004. Chemotherapeutic efficacy of poly (D-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at subtherapeutic dose against experimental tuberculosis. Int. J. Antimicrob. Agents 24:599-604.
9. Smith, D. W., V. Balasubramanian, and E. Wiegeshaus. 1991. A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatment. Tubercle 72:223-231.
10. Stover, C. K., P. Warrener, D. R. VanDevanter, D. R. Sherman, T. M. Arain, M. H. Langhorne, S. W. Anderson, J. A. Towell, Y. Yuan, D. N. McMurray, B. N. Kreiswirth, C. E. Barry, and W. R. Baker. 2000. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405:962-966.
11. Turner, O. C., R. J. Basaraba, A. A. Frank, and I. M. Orme. 2003. Granuloma formation in mouse and guinea pig models of experimental tuberculosis, p. 65-84. In D. L. Boros (ed.), Granulomatous infections and inflammations: cellular and molecular mechanisms. ASM Press, Washington, D.C.